- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00861146
Concurrent Alcohol and Smoking Treatment: Effects on Alcohol Relapse Risk
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Objectives:
Most alcohol and drug treatment programs do not systematically address cigarette smoking during treatment. One obstacle is a concern that smoking cessation early in recovery might increase risk of alcohol relapse. This study followed patients enrolled in intensive outpatient alcohol treatment to compare the effects of a Concurrent Smoking Cessation (CSC) intervention to a Deferred Smoking Cessation (DSC) control group on process measures reflecting risk of alcohol relapse.
Research Design:
Participants were enrolled in intensive outpatient alcohol treatment and then randomized to CSC or DSC groups in a 2:1 ratio. The CSC group received smoking treatment concurrent with intensive alcohol treatment and the DSC group received smoking treatment three months after alcohol treatment. The smoking treatment protocol included behavioral counseling, contingency management with voucher rewards for verified smoking abstinence, and prescribed nicotine patch and gum. During a three-month period after the CSC target smoking quit date, both groups of subjects were asked to participate in a prospective daily monitoring procedure, calling into an Interactive Voice Response system once a day to complete self-report assessments of relapse risk factors. By comparing participants in the CSC group composed of many participants who have stopped smoking with the DSC group who are expected to continue smoking during this daily monitoring period, we will determine the impact of smoking cessation on alcohol relapse risk factors.
Methodology:
This study was conducted in the substance abuse day treatment programs located at Newington and West Haven campuses of VA Connecticut Healthcare System. These are three-week treatment programs meeting Monday-Friday for 4-5 hrs/day. Participants were recruited either before or soon after day program admission. Participants 151 individuals that are 18 years of age or older, meet Diagnostic and Statistical Manual-IV (DSM-IV) criteria for current alcohol abuse or dependence, report currently smoking 1 or more cigarettes per day, and are screened for medical contraindications for nicotine patch and gum use. Dependent variables are process assessments reflecting alcohol relapse risk obtained using daily Interactive Voice Response (IVR) technology. These relapse risk processes include alcohol craving, negative affect, alcohol abstinence self efficacy, alcohol outcome expectancies, motivation for alcohol abstinence, and self-control demands. Given the mixed results from previous clinical trials, we conducted bidirectional tests of the hypothesis that smoking cessation has an impact on alcohol relapse risk factors, examining whether smoking cessation leads to increased or decreased alcohol relapse risk.
Study Type
Enrollment (Actual)
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
Connecticut
-
Newington, Connecticut, United States, 06111
- VA Connecticut Healthcare System
-
West Haven, Connecticut, United States, 06516
- VA Connecticut Healthcare System
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- DSM-IV criteria for alcohol abuse or dependence
- Age 18 or older
- English speaking
- Smoking 1 or more cigarettes/day
- Male or female veterans eligible for VA healthcare
- Female nonveterans also eligible
Exclusion Criteria:
- Allergy or hypersensitivity to nicotine or adhesives used in nicotine patch
- Weigh less than 100 lbs
- Lack of interest in stopping smoking
- Pregnant or lactating females or females not practicing acceptable form of contraception
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: 1 concurrent smoking cessation
smoking cessation delivered concurrent with intensive alcohol treatment
|
Individual counseling sessions with voucher rewards for smoking abstinence, transdermal nicotine patch and nicotine gum
|
Active Comparator: 2 deferred smoking cessation
smoking cessation delivered 12 weeks after intensive alcohol treatment
|
Individual counseling sessions with voucher rewards for smoking abstinence, transdermal nicotine patch and nicotine gum
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Smoking Abstinence
Time Frame: 12 weeks
|
7-day point prevalence smoking abstinence verified by breath carbon monoxide missing coded as smoking
|
12 weeks
|
Smoking Abstinence
Time Frame: 2 weeks
|
7-day point prevalence smoking abstinence verified by breath carbon monoxide missing coded as smoking
|
2 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Proportion of Days Heavy Drinking
Time Frame: follow-up weeks 9-12
|
Heavy drinking days were defined as days with > 6 standard drinks per day for men and > 4 standard drinks per day for women.
This measure examined the proportion of days heavy drinking across 28 days in follow-up weeks 9-12.
|
follow-up weeks 9-12
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Ned L Cooney, PhD, Yale University
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0804003723
- R01AA011197 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Tobacco Use Cessation
-
Claremont Graduate UniversityNational Cancer Institute (NCI)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, CigaretteUnited States
-
Mayo ClinicNational Institute on Drug Abuse (NIDA)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, Tobacco | Smoking, CigaretteUnited States
-
Vanderbilt University Medical CenterCompletedTobacco Use | Tobacco Use Cessation
-
University of MiamiFlorida Department of HealthRecruitingSmoking Cessation | Tobacco Smoking | Tobacco Use CessationUnited States
-
University of VirginiaVirginia Foundation for Healthy YouthRecruitingTobacco Use | Electronic Cigarette Use | Tobacco Use CessationUnited States
-
The University of Hong KongQueen Elizabeth Hospital, Hong Kong; Food and Health Bureau, Hong Kong; Queen... and other collaboratorsCompletedSmoking Cessation | Tobacco Use CessationHong Kong
-
Centre for Addiction and Mental HealthCompletedSmoking Cessation | Tobacco Use CessationCanada
-
SanofiCompletedSmoking Cessation | Tobacco Use CessationUnited States, Canada
-
University of California, Los AngelesNYU Langone Health; Olive View-UCLA Education & Research InstituteEnrolling by invitationSmoking Cessation | Tobacco Use CessationUnited States
-
The University of Hong KongFood and Health Bureau, Hong KongCompletedSmoking Cessation | Tobacco Use CessationHong Kong
Clinical Trials on behavioral counseling plus contingency management
-
Dartmouth-Hitchcock Medical CenterNational Institute on Drug Abuse (NIDA)Completed
-
University of VirginiaUnknownAttention Deficit Hyperactivity DisorderUnited States
-
Centre for Addiction and Mental HealthCompletedMajor Depressive Disorder | Cognition | Cannabis Use DisorderCanada
-
Hospital Clinic of BarcelonaUnknown
-
Medical University of South CarolinaNational Cancer Institute (NCI)Not yet recruitingTobacco Use Disorder | Nicotine Dependence
-
UConn HealthNational Institute on Drug Abuse (NIDA)Completed
-
Vanderbilt UniversityTerminatedObesity | Type 2 Diabetes Mellitus | Exercise | Behavioral ResearchUnited States
-
University of Illinois at Urbana-ChampaignCompletedQuality of Life | Physical Activity | Cognitive Impairment | Cancer of the ProstateUnited States
-
UConn HealthNational Institute of Mental Health (NIMH)Completed
-
Yale UniversityNational Institute on Drug Abuse (NIDA)CompletedSubstance-Related Disorders | Mental DisordersUnited States